PREPARATION AND CHARACTERIZATION OF STAVUDINE ENTRAPPED LIPOSPHERES

Ranjita Shegokar, Kamalinder Singh

Abstract


Lipospheres  of  stavudine  were  prepared  by  melt  dispersion technique  using  trimyristin,  tripalmitin and  triastearin,  stearic acid, Compritol®  888  ATO  and  Precirol®  ATO  5  as  lipid  matrix  in  the various  drug-lipid  ratios.  Drug  entrapped  free  flowing  solid lipospheres  of  triglycerides  and  glyceryl  behenate  were characterized  for  surface  morphology,  particle  size  distribution, encapsulation efficiency, and in vitrorelease behavior. The effect of drug lipid ratio, the surfactant used, concentration of stabilizer, and stirring  speed  were  identified  as  the  key  variables  affecting  the formation  of  discrete  spherical  lipospheres  and  sustained  drug release  rate.  The  lipospheres  production  conditions  were  optimized by using 2% w/w sodium cholate and 1% Plural oleic as a stabilizer. The  concentration  of  lipid  used  had  pronounced  effect  on  particle size of the lipospheres. The incorporation efficiency was found to be in range of 30  to  50%. Increase  in concentration of surfactant and stirring  speed  produced  fine  spherical,  smooth,  and  round lipospheres.  All  the  prepared  lipospheres  exhibited  slow  release profiles dictating the Higuchi mode of release.

Key  words: Lipospheres,  stavudine,  lipid  matrix,  hydrophilic  surfactant, drug release

Full Text:

Untitled

References


Amselem, S., Alving, C.R.,Domb, A.J., Lipospheres for vaccine delivery. Drugs Pharm. Sci., 1996, 77: 149–168.

Alonso, M.J., Nanomedicines for overcoming biological barriers. Biomed. Pharmacother., 2004, 58(3): 168-172.

Attama, A.A., Okafor, C.E., Builders, P.F.,Okorie, O., Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium. Drug Deliv., 2009, 16(8): 448-457.

Bekerman, T., Golenser, J.,Domb, A., Cyclosporin nanoparticulate lipospheres for oral administration. J. Pharm. Sci., 2004, 93(5): 1264-1270.

Cortesi, R., Esposjto, E., Luca, G.,Nastruzzi, C., Production of lipospheres as carriers for bioactive compounds. Biomaterials, 2002, 23(11): 2283-2294.

Elgart, A., Cherniakov, I., Aldouby, Y., Domb, A.J.,Hoffman, A., Lipospheres and pronano lipospheres for delivery of poorly water soluble compounds. Chem. Phys. Lipids, 2012, 165(4): 438-453.

El-Gibaly, I.,Abdel-Ghaffar, S.K., Effect of hexacosanol on the characteristics of novel sustained-release allopurinol solid lipospheres (SLS): factorial design application and product evaluation. Int. J. Pharm., 2005, 294(1-2): 33-51.

Hersh, E.V., Maniar, M., Green, M.,Cooper, S.A., Anesthetic activity of the lipospheres bupivacaine delivery system in the rat. Anesth. Prog., 1992, 39(6): 197-200.

Khopade, A.J.,Jain, N.K., Long-circulating lipospheres targeted to the inflammed tissue. Die Pharmazie, 1997, 52(2): 165-166.

Nasr, M., Mansour, S., Mortada, N.D.,El Shamy, A.A., Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation. AAPS PharmSciTech, 2008, 9(1): 154-162.

Pandit, S.S.,Patil, A.T., Formulation and in vitro evaluation of buoyant controlled release lercanidipine lipospheres. J. Microencapsul., 2009, 26(7): 635-641.

Shivakumar, H.N., Patel, P.B., Desai, B.G., Ashok, P.,Arulmozhi, S., Design and statistical optimization of glipizide loaded lipospheres using response surface methodology. Acta pharmaceutica, 2007, 57(3): 269-285.

Sznitowska, M., Janicki, S., Gajewska, M.,Kulik, M., Investigation of diazepam lipospheres based on Witepsol and lecithin intended for oral or rectal delivery. Acta Pol. Pharm., 2000, 57(1): 61-64.

Takenaga, M., 20, 209, 1996] Application of lipid microspheres for the treatment of cancer. Adv. Drug Del. Rev., 1996, 20: 209-219.

Toongsuwan, S., Li, L.C., Erickson, B.K.,Chang, H.C., Formulation and characterization of bupivacaine lipospheres. Int. J. Pharm., 2004, 280(1-2): 57-65.

Tursilli, R., Casolari, A., Iannuccelli, V.,Scalia, S., Enhancement of melatonin photostability by encapsulation in lipospheres. J. Pharm. Biomed. Anal., 2006, 40(4): 910-914.

Obaru, K.,Mitsuya, H., Anti-HIV drugs and drug delivery system. Nihon Rinsho, 1998, 56(3): 769-775.

Unger, E.C., McCreery, T.P., Sweitzer, R.H., Caldwell, V.E.,Wu, Y., Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest. Radiol., 1998, 33(12): 886-892.

Vyas, S.P., Singh, R.,Dimitrijevic, D., Development and characterization of nifedipine lipospheres. Die Pharmazie, 1997, 52(5): 403-404.




DOI: http://dx.doi.org/10.14499/indonesianjpharm0iss0pp231-237

Refbacks

  • There are currently no refbacks.




Copyright (c) 2017 INDONESIAN JOURNAL OF PHARMACY

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian J Pharm indexed by:

                                    
 
web
analytics View My Stats